Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients

被引:1
作者
Zheng, Jia-Rui [1 ]
Wang, Zi-Long [1 ]
Jiang, Su-Zhen [1 ]
Chen, Hong-Song [1 ]
Feng, Bo [1 ,2 ]
机构
[1] Peking Univ Peoples Hosp, Hepatol Inst, Beijing 100044, Peoples R China
[2] Peking Univ Peoples Hosp, Hepatol Inst, 11 Xizhimen South St, Beijing 100044, Peoples R China
关键词
Non-alcoholic fatty liver disease; Alanine aminotransferase; Mortality; NHANES-III; BODY-MASS INDEX; INSULIN-RESISTANCE; PREDICT MORTALITY; NATIONAL-HEALTH; DISEASE; RISK; NAFLD; SEVERITY; ADULTS;
D O I
10.4254/wjh.v15.i6.813
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDSerum alanine aminotransferase (ALT) levels are often considered a marker to evaluate liver disease and its severity.AIMTo investigate the association between ALT levels and all-cause and cause-specific mortality in patients with nonalcoholic fatty liver disease (NAFLD).METHODSThe Third National Health and Nutrition Examination Survey (NHANES-III) from 1988 to 1994 and NHANES-III-related mortality data from 2019 onward were used to obtain the necessary data for the study. NAFLD was defined as hepatic steatosis, as diagnosed by ultrasound, with no other liver diseases. ALT levels were categorized into four groups according to the different recommended upper limits of normal (ULN) in men and women: < 0.5 ULN, 0.5-1 ULN, 1-2 ULN, and & GE; 2 ULN. The hazard ratios for all-cause mortality and cause-specific mortality were analyzed using the Cox proportional hazard model.RESULTSMultivariate logistic regression analysis demonstrated that the odds ratio of NAFLD correlated positively with increased serum ALT levels. In patients with NAFLD, all-cause mortality and cardiovascular mortality were the highest when ALT was < 0.5 ULN, yet cancer-related mortality was the highest when ALT was = 2 ULN. The same results could be found in both men and women. Univariate analysis showed that severe NAFLD with normal ALT levels had the highest all-cause and cause-specific mortality, but the difference was not statistically significant after adjustment for age and multivariate factors.CONCLUSIONThe risk of NAFLD was positively correlated with ALT level, but all-cause and cardiovascular mortality were the highest when ALT was < 0.5 ULN. Regardless of the severity of NAFLD, normal or lower ALT levels were associated with higher mortality than elevated ALT levels. Clinicians should be aware that high ALT levels indicate liver injury, but low ALT levels are associated with a higher risk of death.
引用
收藏
页码:813 / 825
页数:13
相关论文
共 47 条
[1]  
Akabame S, 2008, CIRC J, V72, P618
[2]  
Amarapurka D N, 2006, Ann Hepatol, V5, P30
[3]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[4]   Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort [J].
Armstrong, Matthew J. ;
Houlihan, Diarmaid D. ;
Bentham, Louise ;
Shaw, Jean C. ;
Cramb, Robert ;
Olliff, Simon ;
Gill, Paramjit S. ;
Neuberger, James M. ;
Lilford, Richard J. ;
Newsome, Philip N. .
JOURNAL OF HEPATOLOGY, 2012, 56 (01) :234-240
[5]   Risk of metabolic syndrome in participants within the normal range of alanine aminotransferase: A population-based nationwide study [J].
Cho, Ju-Yeon ;
Jeong, Jae Yoon ;
Sohn, Won .
PLOS ONE, 2020, 15 (04)
[6]   Severity of metabolic syndrome is greater among nonalcoholic adults with elevated ALT and advanced fibrosis [J].
DeBoer, Mark D. ;
Lin, Boya ;
Filipp, Stephanie L. ;
Cusi, Kenneth ;
Gurka, Matthew J. .
NUTRITION RESEARCH, 2021, 88 :34-43
[8]   Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories A Systematic Review and Meta-analysis [J].
Flegal, Katherine M. ;
Kit, Brian K. ;
Orpana, Heather ;
Graubard, Barry I. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (01) :71-82
[9]   Mechanisms of NAFLD development and therapeutic strategies [J].
Friedman, Scott L. ;
Neuschwander-Tetri, Brent A. ;
Rinella, Mary ;
Sanyal, Arun J. .
NATURE MEDICINE, 2018, 24 (07) :908-922
[10]   Future therapy for non-alcoholic fatty liver disease [J].
Issa, Danny ;
Patel, Vaishali ;
Sanyal, Arun J. .
LIVER INTERNATIONAL, 2018, 38 :56-63